|
CN109922836A
|
|
It is use for cancer treatment through modify antibody-albumin nanoparticle compound
|
|
WO2017173203A1
|
|
Methods and materials for assessing intestinal permeability
|
|
WO2017172734A1
|
|
Treating cancer metastasis
|
|
WO2017165439A1
|
|
Methods for improving the therapeutic index for a chemotherapeutic drug
|
|
WO2017160783A1
|
|
Shear wave group velocity estimation using spatiotemporal peaks and amplitude thresholding
|
|
US2017260571A1
|
|
Methods and materials for treating endometrial cancer
|
|
WO2017152030A1
|
|
Transoral surgical devices and methods
|
|
WO2017151714A1
|
|
System and method for reinforced polymer composites in medical devices and instrumentation
|
|
WO2017139698A1
|
|
Hematologic cancer treatments
|
|
WO2017136198A1
|
|
Methods and materials for extracting chromatin
|
|
WO2017127170A1
|
|
Monovalent anti-cd3 adjuvants
|
|
WO2017096133A1
|
|
Thermal modification to treat cardiac electrical disorders and other disorders
|
|
WO2017087510A1
|
|
Detecting copy number variations
|
|
WO2017095632A1
|
|
Heatr1 as a marker for chemoresistance
|
|
WO2017062434A1
|
|
Homologous recombination deficiency-interstitial aberration (hrd-ia) assay
|
|
US2017103537A1
|
|
Determining image features for analytical models using s-transform
|
|
WO2017044615A1
|
|
Methods and materials for treating cancer
|
|
US2017057175A1
|
|
System and method for five-dimensional additive manufacturing
|
|
WO2017015027A1
|
|
Methods and materials for treating cancer
|
|
WO2017027143A1
|
|
Endoluminal anastomosis and tissue closure devices
|
